A recent human trial failed to show benefit from NMN supplementation.
"Effect of oral administration of nicotinamide mononucleotide on clinical parameters and nicotinamide metabolite levels in healthy Japanese men" (2019) https://www.jstage.j...9-0313/_article
You are misrepresenting or misunderstanding the trial.
How can a study fail to show benefit when it was not designed to do so?
The study you posted was a one-time single dose safety study of oral NMN. It was ONE PILL. It didn´t look at long-term efficacy of anything. Those studies are yet to be published.
"A single-arm non-randomized intervention was conducted by single oral administration of 100, 250, and 500 mg NMN."
They only looked at SAFETY:
"The single oral administration of NMN was safe and effectively metabolized in healthy men without causing any significant deleterious effects."
Edited by Fredrik, 13 November 2019 - 12:11 PM.